諾科達科技(00519.HK)中期收益同比減少35%至1446萬港元
格隆匯2月28日丨諾科達科技(00519.HK)公吿,截至2024年12月31日止6個月中期業績,集團的收益同比減少35%至1446萬港元。公司錄得虧損7387.9萬港元,而於截至2023年12月31日止6個月虧損為3556.4萬港元。董事不建議就截至2024年12月31日止6個月派付中期股息(2023年:無)。
截至2023年12月31日止6個月產生的大部分收益來自物業發展分部,且無錫盛業的物業已交付予客户並帶來收益。截至2024年12月31日止6個月,收益變得多元化。毛利率增加乃由於毛利率較高的物業投資分部及其他分部產生收益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.